| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |